Showing 16,561 - 16,580 results of 122,478 for search '(( 2 d decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.96s Refine Results
  1. 16561

    Flow chart of study inclusion. by Shayan Shirazian (9922110)

    Published 2023
    “…The intervention led to modest, but non-significant, increase in KDQOL-physical component summary scores (+3.1±1.2 points) from week 0 to week 16. There were small, non-significant decreases in interdialytic weight gain and pre-dialysis phosphorus levels in the intervention group. …”
  2. 16562

    Baseline characteristics of the study population. by Shayan Shirazian (9922110)

    Published 2023
    “…The intervention led to modest, but non-significant, increase in KDQOL-physical component summary scores (+3.1±1.2 points) from week 0 to week 16. There were small, non-significant decreases in interdialytic weight gain and pre-dialysis phosphorus levels in the intervention group. …”
  3. 16563
  4. 16564
  5. 16565
  6. 16566

    SS induces breast cancer cell apoptosis, G2/M checkpoint arrest, ROS accumulation and LDH-A inhibition. by Zhiyu Wang (282312)

    Published 2013
    “…<p>(A) Annexin-Cy5 staining results showed that SS induced both breast cancer cells apoptosis in a dose-dependent manner; (B) JC-1 staining assay indicated that mitochondrial membrane potential was decreased after SS treatment, indicating that the mitochondrial pathway apoptosis was triggered by SS; (C) Cell cycle analysis showed that after SS treatment, the G2/M checkpoint was arrested in both breast cancer cell lines, presenting as a significant increase in G2/M subpopulations; (D) Hydroethidine was applied to detect the intracellular O<sub>2</sub><sup>−</sup> level after SS administration by flow cytometry. …”
  7. 16567

    Mutation S223N in HA negatively affects self-elution from LAMP1 containing increased levels of α2,6 SIAs (6’LAMP1). by Wenjuan Du (393238)

    Published 2020
    “…We conclude that 6’LAMP1 contains increased levels of α2,6 SIAs and decreased levels of α2,3 SIAs. (C and D) NA-driven self-elution from 6’LAMP-coated sensors was analyzed for the indicated viruses (same stocks and amounts as used in in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1008816#ppat.1008816.g002" target="_blank">Fig 2</a>) as described in the legend to <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1008816#ppat.1008816.g001" target="_blank">Fig 1</a>. …”
  8. 16568
  9. 16569
  10. 16570

    Supplementary Material for: Behavioral Conditioning of Immune Responses with Cyclosporine A in a Murine Model of Experimental Autoimmune Uveitis by Bauer D. (4396777)

    Published 2017
    “…<b><i>Methods:</i></b> Mice received a 0.2% w/v saccharin solution as conditioned stimulus combined with CsA (20 mg/kg) in 6 association trials at 72-h intervals. …”
  11. 16571
  12. 16572

    Transcription factor c-Jun activation and cell viability in SH-SY5Y cell line following stimulation with H<sub>2</sub>O<sub>2</sub> for 3 h. by Marco Feligioni (287395)

    Published 2013
    “…Application of D-JNKI1, 30 min prior to H<sub>2</sub>O<sub>2</sub> stimulation decreased P-c-Jun activation. …”
  13. 16573

    Possible scenarios explaining a changing Impact Factor (IF). by Tobias Kiesslich (292510)

    Published 2016
    “…<p>(A) Based on theoretical considerations regarding the potential influence of the variables (citations and article numbers) on the final calculation (i.e. the IF quotient), 13 scenarios are possible which either cause an increased (a1-a5), constant (b1-b3) or decreased IF (c1-c3). …”
  14. 16574

    Summary statistics of main outcomes. by Anita Svadzian (15927140)

    Published 2023
    “…To assess the difference in case management and the use of drugs across the two cases by round, a difference in difference (DiD) model was employed. …”
  15. 16575

    Summary statistics of main outcomes by case. by Anita Svadzian (15927140)

    Published 2023
    “…To assess the difference in case management and the use of drugs across the two cases by round, a difference in difference (DiD) model was employed. …”
  16. 16576

    Standardised patient case descriptions. by Anita Svadzian (15927140)

    Published 2023
    “…To assess the difference in case management and the use of drugs across the two cases by round, a difference in difference (DiD) model was employed. …”
  17. 16577

    FIGURE 6 from D-2-HG Inhibits <i>IDH1<sup>mut</sup></i> Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation by Sean T. Pianka (18237413)

    Published 2024
    “…<p>ATF5 is a downstream mediator of the <i>IDH1<sup>mut</sup></i> → D-2-HG ⊣ FTO axis leading to gliomasphere growth reduction. …”
  18. 16578
  19. 16579
  20. 16580

    Analyze data. by Xinhui Zhang (1624039)

    Published 2025
    “…Compared with the Sham surgery group, there was a significant decrease in NeuN over time (P < 0.01) and a significant increase in IBA-1 and CIRBP (P < 0.01) in the severe injury group. …”